Zobrazeno 1 - 10
of 34
pro vyhledávání: '"James K. Schwarz"'
Autor:
Koji Kawai, Satoshi Nagamori, Katherine M Bell-McGuinn, Cristiano Ferrario, Wen Pin Su, Isabel Syndikus, Aude Flechon, Georgios Gakis, Timothy Dudley Clay, Leticia Vazquez Cortés, Ronald de Wit, Florence Joly, Bozena Sikora-Kupis, Sergio Bracarda, Astra M. Liepa, Annemie Rutten, Daniel P. Petrylak, Su Peng Yeh, Annamaria Zimmermann, Sameera R. Wijayawardana, Mutsushi Kawakita, Siobhan Ng, Thean Hsiang Tan, Chikara Ohyama, Yu Jung Kim, Yuriy Golovko, Dimitrios Mavroudis, Jian Ri Li, Reinoud J. B. Blaisse, Mustafa Erman, Francesca Russo, Catherine Becht, Anghel Adrian Udrea, Robert Huddart, Syed A. Hussain, Fransiscus L.G. Erdkamp, Satoshi Fukasawa, Francesco Massari, Motohide Uemura, Boris Alekseev, Irfan Cicin, Se Hoon Park, Marcello Tucci, Lajos Géczi, Maureen J.B. Aarts, Yu Li Su, Fumimasa Fukuta, Hyo Jin Lee, Wolfgang Schultze-Seemann, Alexandra Drakaki, Hakan Harputluoglu, Xavier Garcia del Muro, Santhanam Sundar, Avivit Peer, Herlinde Dumez, William E. Lawler, Juan Ignacio Delgado Mignorance, Naveed Sarwar, Jeanny B. Aragon-Ching, Benjamin T. Herms, Fredrik Laestadius, Nobuaki Matsubara, Ivan Sinielnikov, Cora N. Sternberg, Hiroyuki Nishiyama, Piotr Tomczak, Brigitte Laguerre, Rebecca R. Hozak, Vasilis Karavasilis, Christina A. Schwentner, Hiroyuki Tsunemori, Masayoshi Nagata, Igor Bondarenko, Andrea Necchi, Yen Chuan Ou, Scott T. Tagawa, Constance Thibault, Richard A. Walgren, Akira Yokomizo, Evan Y. Yu, Alejo Rodriguez-Vida, Sufia Safina, Ulka N. Vaishampayan, János Révész, Aristotelis Bamias, Jae-Lyun Lee, Chien Liang Lin, Thomas W. Flaig, Roman Fomkin, Petr Alexandrovich Karlov, Joanna Wojcik-Tomaszewska, Junichi Inokuchi, Wataru Obara, Haralambos Kalofonos, John D. Hainsworth, Marc-Oliver Grimm, Thomas Eugene Lowe, Pablo Gajate Borau, Simon J. Crabb, Lisa Sengeloev, Junji Yonese, Simon Chowdhury, Elizabeth Jane Hovey, Daniel Castellano, Peter Istvan Acs, Chia-Chi Lin, Claudia Lorena Urzua Flores, Jean-Pascal Machiels, Kim N. Chi, Takahiro Osawa, Nobuo Shinohara, Daniel Kejzman, Günter Niegisch, David Sarid, Yuksel Urun, Yun Gyoo Lee, Oday Hamid, Alina Amalia Herzal, Michael Schenker, Eli Rosenbaum, Enrique Grande, Raya Leibowitz-Amit, Naoto Miyajima, Michiel S. van der Heijden, Shinichi Yamashita, Susanna Yee Shan Cheng, Kazuo Nishimura, Sun Young Rha, Thomas Powles, Hasan Şenol Coşkun, Jens Bedke, Ivor J. Percent, Christos Papandreou, James K. Schwarz, Masafumi Oyama, Giorgio V. Scagliotti, Chong-Xian Pan, Yoshihiko Tomita, Giampaolo Tortora, Stéphane Culine, Suet Lai Shirley Wong, Andrey Semenov, Jennifer L. Cultrera, Niels Viggo Jensen, Michael Stöckle, Katsuyoshi Hashine
Publikováno v:
Lancet Oncology, 21(1), 105-120. Lancet Publishing Group
The Lancet. Oncology, Vol. 21, no.1, p. 105-120 (2020)
Lancet oncology, 21(1), 105-120. Elsevier Science
lancet oncology, 21(1), 105-120. Lancet Publishing Group
The Lancet. Oncology, Vol. 21, no.1, p. 105-120 (2020)
Lancet oncology, 21(1), 105-120. Elsevier Science
lancet oncology, 21(1), 105-120. Lancet Publishing Group
Background Ramucirumab-an IgG1 vascular endothelial growth factor receptor 2 antagonistplus docetaxel was previously reported to improve progression-free survival in platinum-refractory, advanced urothelial carcinoma. Here, we report the secondary en
Autor:
James C. Padussis, Jane L. Meza, Quan P. Ly, Michael A. Hollingsworth, Chandrakanth Are, Audrey J. Lazenby, Vivek Verma, Chi Lin, Madi Madiyalakan, Christopher F. Nicodemus, Lyudmyla Berim, Jean L. Grem, James K. Schwarz
Publikováno v:
Am J Clin Oncol
Objective Cancer antigen (CA)-125 influences progression, metastasis, and outcomes in pancreatic cancer. This phase I/II trial (NCT01959672) evaluated the safety, efficacy, and immunologic correlates of chemoimmunotherapy (CIT) with oregovomab (anti-
Autor:
Chi Lin, Jane L. Meza, Chandrakanth Are, Stephen M. Hahn, Jean L. Grem, Shuo Wang, James K. Schwarz, Vivek Verma, Aaron R. Sasson, Audrey J. Lazenby, Sicong Li, Quan P. Ly
Publikováno v:
Radiotherapy and Oncology. 132:55-62
Introduction The HIV protease inhibitor nelfinavir (NFV) displays notable radiosensitizing effects. There have been no studies evaluating combined stereotactic body radiotherapy (SBRT) and NFV for borderline/unresectable pancreatic cancer. The primar
Autor:
Shilpa Gupta, Monika Joshi, James K. Schwarz, Joshua M. Lang, Arkadiusz Z. Dudek, Ajjai Alva, Yousef Zakharia, Li C Liu, Anas Al-Janadi, Eric A. Singer, Theodore F. Logan
Publikováno v:
Journal of Clinical Oncology
PURPOSE We hypothesized that bevacizumab will potentiate activity of pembrolizumab. We conducted a phase Ib/II, single-arm, multisite clinical trial of the combination in metastatic renal cell carcinoma (RCC). PATIENTS AND METHODS Patients with metas
Autor:
James K. Schwarz, Ashok Kumar Gupta, Mary Tagliaferri, David R. Spigel, R. Saab, Delvys Rodriguez-Abreu, Daniel C. Cho, Martin Reck, Frederico Cappuzzo, T. Chan, Wen Hong Lin, Matthew J. Riese, S. Singel
Publikováno v:
Annals of Oncology. 30:xi46-xi47
Background Checkpoint Inhibitors (CPIs), are now part of standard treatment in many advanced solid tumors, including metastatic non-small cell lung cancer (mNSCLC). However, novel, more effective CPI combinations are needed to broaden, deepen, and pr
Publikováno v:
Cancer. 121:3862-3868
Pralatrexate (PDX) is an inhibitor of dihydrofolate reductase that was rationally designed to improve cellular uptake and retention of the drug. Preclinical data have shown synergy with the sequential administration of a dihydrofolate reductase inhib
Publikováno v:
Journal of the National Comprehensive Cancer Network. 13:508-514
Old age (≤65 years), relapsed or refractory disease, and the presence of FMS-like receptor tyrosine kinase-3 (FLT3) internal tandem duplication (ITD) mutation are poor prognostic factors in acute myeloid leukemia (AML). FLT3 inhibitors such as sora
Publikováno v:
Future Oncology. 10:703-706
With 65,000 new cases in the USA in 2013, the incidence of kidney cancer has doubled in last decade and accounted for 13,600 deaths in 2013 [1,2]. Renal cell carcinoma (RCC), which consists of 80% of kidney cancers in adults [3], presents with advanc
Autor:
Quan P. Ly, Jean L. Grem, Vivek Verma, Aaron R. Sasson, James K. Schwarz, Jane L. Meza, Beth M Kos, Chi Lin, Chandrakanth Are
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 102:S135
Autor:
Nicholas J. Vogelzang, Jonathan Zalevsky, Sunny Xie, Mary Tagliaferri, Matthew J. Riese, A. Eli Gabayan, Daniel C. Cho, Daniel A. Vaena, James K. Schwarz, Michael Imperiale, Sandra Aung, Ute Hoch, Ahsan Naqi Rizwan, Marc R. Matrana, Jorge Chaves
Publikováno v:
Journal of Clinical Oncology. 36:TPS3115-TPS3115
TPS3115Background: NKTR-214 is an investigational cytokine designed to target CD122 (IL-2Rβ) expressed on immune cells (CD8+ T cells and NK cells) in order to expand these tumor-killing cells. NKTR...